|
ZNF252 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74260605945165E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.81805698168591E-13 |
| Normal-vs-Stage2 |
3.77030000000556E-05 |
| Normal-vs-Stage3 |
9.99200722162641E-16 |
| Normal-vs-Stage4 |
1.11022302462516E-16 |
| Stage1-vs-Stage2 |
9.153800E-04 |
| Stage1-vs-Stage3 |
1.624430E-02 |
| Stage1-vs-Stage4 |
2.940900E-03 |
| Stage2-vs-Stage3 |
6.19669999999406E-05 |
| Stage2-vs-Stage4 |
3.50959999995126E-06 |
| Stage3-vs-Stage4 |
2.323800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64734892393881E-12 |
| Normal-vs-AfricanAmerican |
5.18330045551352E-10 |
| Normal-vs-Asian |
1.5251999663235E-10 |
| Caucasian-vs-AfricanAmerican |
6.397600E-01 |
| Caucasian-vs-Asian |
2.439000E-01 |
| AfricanAmerican-vs-Asian |
7.044400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.34807786734382E-14 |
| Normal-vs-Female |
1.83519865970538E-13 |
| Male-vs-Female |
5.451400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.72450942415026E-12 |
| Normal-vs-Age(41-60Yrs) |
1.668998272919E-12 |
| Normal-vs-Age(61-80Yrs) |
9.7373220597774E-12 |
| Normal-vs-Age(81-100Yrs) |
3.9037000000075E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.554000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.889980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.090800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.986000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.782400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.518800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.220000E-04 |
| Classical-VS-Follicular |
1.296010E-03 |
| Classical-VS-Other |
6.662400E-01 |
| Classical-VS-Normal |
1.50324197534246E-13 |
| Tall-VS-Follicular |
1.44619999975504E-07 |
| Tall-VS-Other |
4.045400E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
1.843950E-01 |
| Follicular-VS-Normal |
3.63259999858201E-08 |
| Other-VS-Normal |
3.553500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
3.33066907387547E-16 |
| N0-vs-N1 |
4.838400E-04 |
|
|
